COVID-19 in women with rheumatic disease who are pregnant: Data from the COVID-19 Global Rheumatology Alliance
CONCLUSION: Women with rheumatic diseases who were pregnant at the time of COVID-19 had favourable outcomes. These data have limitations due to the small size and methodology, though they provide cautious optimism for pregnancy outcomes for women with rheumatic disease given the increased risk of poor outcomes that have been reported in other series of pregnant women with COVID-19.PMID:34470798 | DOI:10.3899/jrheum.210480
Source: Journal of Rheumatology - Category: Rheumatology Authors: Bonnie L Bermas Milena Gianfrancesco Helen L Tanner Andrea M Seet Mathia C Aguiar Nasra K Al Adhoubi Samar Al Emadi Bernardo M Cunha Rachael Flood Daria A Kusevich Eoghan M McCarthy Naomi J Patel Eric Ruderman Sebastian E Sattui Savino Sciascia Faizah Sid Source Type: research
More News: Arthritis | Azithromycin | Colchicine | Colcrys | Coronavirus | COVID-19 | Kaletra | Lupus | Miscarriage | Norvir | OBGYN | Pregnancy | Rheumatoid Arthritis | Rheumatology | Women | Zithromax